These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
373 related items for PubMed ID: 16317756
1. Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the General Practice Research Database. Högler W, Wehl G, van Staa T, Meister B, Klein-Franke A, Kropshofer G. Pediatr Blood Cancer; 2007 Jan; 48(1):21-7. PubMed ID: 16317756 [Abstract] [Full Text] [Related]
3. Skeletal morbidity in children receiving chemotherapy for acute lymphoblastic leukemia and its association with mineral homeostasis and duration of inpatient stay. Elmantaser ME, Young D, Gibson B, Ahmed SF. J Pediatr Hematol Oncol; 2011 Oct; 33(7):516-20. PubMed ID: 21941144 [Abstract] [Full Text] [Related]
8. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia. van der Sluis IM, van den Heuvel-Eibrink MM, Hählen K, Krenning EP, de Muinck Keizer-Schrama SM. J Pediatr; 2002 Aug; 141(2):204-10. PubMed ID: 12183715 [Abstract] [Full Text] [Related]
12. Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols. Barry E, DeAngelo DJ, Neuberg D, Stevenson K, Loh ML, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin M, Cohen HJ, Sallan SE, Silverman LB. J Clin Oncol; 2007 Mar 01; 25(7):813-9. PubMed ID: 17327603 [Abstract] [Full Text] [Related]
13. Pneumocystis carinii pneumonia during maintenance treatment of childhood acute lymphoblastic leukemia. Poulsen A, Demeny AK, Bang Plum C, Gjerum Nielsen K, Schmiegelow K. Med Pediatr Oncol; 2001 Jul 01; 37(1):20-3. PubMed ID: 11466718 [Abstract] [Full Text] [Related]
16. Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood. Borgmann A, Zinn C, Hartmann R, Herold R, Kaatsch P, Escherich G, Möricke A, Henze G, von Stackelberg A, ALL-REZ BFM Study Group. Eur J Cancer; 2008 Jan 01; 44(2):257-68. PubMed ID: 17981026 [Abstract] [Full Text] [Related]
17. [Childhood acute lymphoblastic leukemia in Norway 1992-2000]. Kolmannskog S, Flaegstad T, Helgestad J, Hellebostad M, Zeller B, Glomstein A. Tidsskr Nor Laegeforen; 2007 May 31; 127(11):1493-5. PubMed ID: 17551551 [Abstract] [Full Text] [Related]
18. [Infectious complications of the treatment of acute lymphoblastic leukemia in children]. Rubie H, Assouline C, Prere MF, Dutour A, Lemozy J, Mouls JL, Gayet-Mengelle C, Robert A. Pediatrie; 1990 May 31; 45(5):333-8. PubMed ID: 2165247 [Abstract] [Full Text] [Related]
19. Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)--experiences from trial ALL-BFM 95. Bürger B, Beier R, Zimmermann M, Beck JD, Reiter A, Schrappe M. Pediatr Blood Cancer; 2005 Mar 31; 44(3):220-5. PubMed ID: 15514916 [Abstract] [Full Text] [Related]
20. Incidence of fractures among epilepsy patients: a population-based retrospective cohort study in the General Practice Research Database. Souverein PC, Webb DJ, Petri H, Weil J, Van Staa TP, Egberts T. Epilepsia; 2005 Feb 31; 46(2):304-10. PubMed ID: 15679512 [Abstract] [Full Text] [Related] Page: [Next] [New Search]